OV2089 : Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores
  • $395.00
Microarray Panel Ovarian carcinoma tissue microarray (slide 5 of 520 cases of ovary cancer survey slide set), containing 104 cases of malignant tumor (62 serous adenocarcinoma, 1 mixed epithelial tumour, 10 mucinous adenocarcinoma, 4 adenocarcinoma, 5 endometrioid adenocarcinoma, 1 embryonal carcinoma, 6 endodermal sinus carcinoma, 4 dysgerminoma, 6 granulosa cell tumor, 1 each of granulosa-theca cell tumor and theca cell tumor, 2 squamous cell carcinoma, 1 sertoli-leydig cell tumor), duplicate cores per case
Cores 208

Cases 104
Row number 13
Column number 16
Core Diameter (mm) 1
Thickness (µm) 5
QA/QC Anti-Actin confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: US Biomax, Inc. Tissue Array
12345678910111213141516 
AOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
BOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
COvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
DOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
EOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
FOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
GOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
HOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
IOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
JOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
KOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
LOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
MOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaMarked point
Legend: Ova - Ovary

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic)

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.

TNM and FIGO classification, staging of tumors of the ovary, fallopian tube and primary peritoneal carcinoma:
TNM Primary tumor (T) and FIGO stages in ( )
• TX: Primary tumor cannot be assessed
• T0: No evidence of primary tumor
• T1(I): Tumor limited to the ovaries
• T1a(IA): Tumor limited to one ovary (capsule intact) or fallopian tube surface; no malignant cells in ascites or peritoneal washings
• T1b(IB): Tumor limited to one or
both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface, no malignant cells in ascites or peritoneal washings
• T1c(IC): Tumor limited to one or both ovaries or fallopian tubes with any of following:
• T2a(IIA): Extension and/or implants on uterus and/or fallopian tubes and/or ovaries; no malignant cells in ascites or peritoneal washings
• T2b(IIB): Extension to other pelvic intraperitoneal tissues
• T3(III): Tumor involves one or both ovaries or fallopian tubes, or primary and/or peritoneal cancer, with cytologically or histologically confirmed
• T3a(IIIA): Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes
• T3b(IIIB): Macroscopic peritoneal metastasis beyond pelvis up to 2 cm in greatest dimension or less in greatest dimension with or without retroperitoneal lymph node metastasis
• T3c(IIIC): Macroscopic peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension with or without retroperitoneal lymph node metastasis (excludes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ
TRegional lymph nodes (N) and FIGO stages in ( )
• NX: Regional lymph nodes cannot be assessed
• N0: No regional lymph node metastasis
• N1 (IIIC): Regional lymph node metastasis
TDistant metastasis (M) and FIGO stages in ( )
• M0: No distant metastasis
• M1 (IV): Distant metastasis

Find overlapping cases with this tissue array: